We value your privacy

We use cookies to enhance your browsing experience, serve personalized content, and analyze our traffic. By clicking "Accept All", you consent to our use of cookies. Cookie Policy. By using this site you agree to our Terms and Conditions.

ortex-logo-h
​
​
Nasdaq:CCCC
​
​
logo

C4 Therapeutics (CCCC)

Nasdaq • CCCC • US12529R1077

3.00Last close
Market Closed
Overview
Fundamentals
Events
News
Corp Actions
Index
Analysts
EPS Momentum
Holders
Dividend
Options
Shorts
Insiders
Peers
Commodity Exp
Trading Signals
Stock Scores

ORTEX Data Highlights

As of Oct 26, 2026, ORTEX estimated 43.2% of free float sold short, 16.7 days to cover, cost to borrow 0.56%. Sign up for live short interest data.

Market Cap

395m USD | # 6372 in US

Volume

2.5m shares | 8.49m USD

Shares Outstanding

131.32m

Free Float Shares

78.28% | 102.79m

News

CCCC key data

C4 Therapeutics (Nasdaq: CCCC) has a market capitalization of $394.61M. Last close $3.01 (as of 2026-11-11); 52-week range $1.69 to $5.17. ORTEX data as of 2026-10-26: short interest was 43.15% of free float, 16.7 days to cover and the average cost to borrow was 0.56%. Sign up for live short interest data.

  • CCCC news on ORTEX News
  • ORTEX News
  • ORTEX public data
  • ORTEX Charts
  • ORTEX API

© 2026 ORTEX Technologies Ltd.